A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

Author： Horsley Laura   Cummings Jeff   Middleton Mark   Ward Tim   Backen Alison   Clamp Andrew   Dawson Martin   Farmer Hayley   Fisher Nita   Halbert Gavin   Halford Sarah   Harris Adrian   Hasan Jurjees   Hogg Philip   Kumaran Gireesh   Little Ross   Parker Geoff   Potter Paula   Saunders Mark   Roberts Caleb   Shaw Danielle   Smith Nigel   Smythe Jon   Taylor Andrew   Turner Helen   Watson Yvonne   Dive Caroline   Jayson Gordon  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.6, 2013-12, pp. : 1343-1352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase 1 study of N 1,N 11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma

By Goyal Lipika   Supko Jeffrey   Berlin Jordan   Blaszkowsky Lawrence   Carpenter Amanda   Heuman Douglas   Hilderbrand Sarah   Stuart Keith   Cotler Scott   Senzer Neil   Chan Emily   Berg Carl   Clark Jeffrey   Hezel Aram   Ryan David   Zhu Andrew  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1305-1314

Springer Publishing Company

Access to resources Recommend Favorite

MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours

By Crona Joakim   Maharjan Rajani   Delgado Verdugo Alberto   Stålberg Peter   Granberg Dan   Hellman Per   Björklund Peyman  

Familial Cancer, Vol. 13, Iss. 1, 2014-03 ,pp. : 121-125

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies

By Schaar Dale   Goodell Lauri   Aisner Joseph   Cui Xiao   Han Zheng   Chang Richard   Martin John   Grospe Stephanie   Dudek Liesel   Riley Joan   Manago Jacqueline   Lin Yong   Rubin Eric   Conney Allan   Strair Roger  

Cancer Chemotherapy and Pharmacology, Vol. 57, Iss. 6, 2006-06 ,pp. : 789-795

Springer Publishing Company

Access to resources Recommend Favorite

Relationship Between Advanced Oxidation Protein Products, Advanced Glycation End Products, and S-Nitrosylated Proteins With Biological Risk and MDR-1 Polymorphisms in Patients Affected by B-Chronic Lymphocytic Leukemia

By Gangemi Sebastiano   Allegra Alessandro   Aguennouz Mohamed   Alonci Andrea   Speciale Antonio   Cannavò Antonino   Cristani Mariateresa   Russo Sabina   Spatari Giovanna   Alibrandi Angela   Musolino Caterina  

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 20-26

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer

By Song Hunho   Han Boram   Park Choong   Kim Jong   Jeon Jang   Kim In-Gyu   Kim Hyo   Jung Joo   Kim Jung   Kwon Jung   Jang Geundoo   Kim Ho   Kim Hyeong   Choi Dae   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 845-852

Springer Publishing Company

Access to resources Recommend Favorite